Precision nanomedicine in neurodegenerative diseases

ACS Nano

Volumn 8, Issue 3, 2014, Pages 1958-1965

  Goldsmith, Meir ^a   Abramovitz, Lilach ^a   Peer, Dan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; MEDICAL NANOTECHNOLOGY; MOLECULES; NEUROPHYSIOLOGY; PEPTIDES;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEMS; CHRONIC DISEASE; EFFECTIVE APPROACHES; MULTIPLE STRATEGY; NANO-STRUCTURED; PROTEIN DELIVERY CARRIERS; THERAPEUTIC MODALITY;

NEURODEGENERATIVE DISEASES;

ANIMAL; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DRUG EFFECT; EDITORIAL; HUMAN; METABOLISM; METHODOLOGY; NANOMEDICINE;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; NANOMEDICINE; NEURODEGENERATIVE DISEASES;

EID: 84896959384     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn501292z     Document Type: Article

References (67)

1. Mayeux, R. Epidemiology of Neurodegeneration Annu. Rev. Neurosci. 2003, 26, 81-104
2. Querfurth, H. W.; LaFerla, F. M. Alzheimer's Disease N. Engl. J. Med. 2010, 362, 329-344
3. Skovronsky, D. M.; Lee, V. M.; Trojanowski, J. Q. Neurodegenerative Diseases: New Concepts of Pathogenesis and Their Therapeutic Implications Anni. Rev. Pathol. 2006, 1, 151-170
4. de Boer, A. G.; Gaillard, P. J. Strategies To Improve Drug Delivery Across the Blood-Brain Barrier Clin. Pharmacokinet. 2007, 46, 553-576
5. Pardridge, W. M. Drug Transport Across the Blood-Brain Barrier J. Cereb. Blood Flow Metab. 2012, 32, 1959-1972
6. Pasha, S.; Gupta, K. Various Drug Delivery Approaches to the Central Nervous System Expert Opin. Drug Delivery 2010, 7, 113-135
7. Kabanov, A. V.; Batrakova, E. V. New Technologies for Drug Delivery Across the Blood Brain Barrier Curr. Pharm. Des. 2004, 10, 1355-1363
8. Aryal, M.; Vykhodtseva, N.; Zhang, Y.-Z.; Park, J.; McDannold, N. Multiple Treatments with Liposomal Doxorubicin and Ultrasound-Induced Disruption of Blood-Tumor and Blood-Brain Barriers Improve Outcomes in a Rat Glioma Model J. Controlled Release 2013, 169, 103-111
9. McDannold, N.; Arvanitis, C. D.; Vykhodtseva, N.; Livingstone, M. S. Temporary Disruption of the Blood-Brain Barrier by Use of Ultrasound and Microbubbles: Safety and Efficacy Evaluation in Rhesus Macaques Cancer Res. 2012, 72, 3652-3663
10. Craft, S.; Baker, L. D.; Montine, T. J.; Minoshima, S.; Watson, G. S.; Claxton, A.; Arbuckle, M.; Callaghan, M.; Tsai, E.; Plymate, S. R. et al. Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment: A Pilot Clinical Trial Arch. Neurol. 2012, 69, 29-38
11. Burov, S.; Leko, M.; Dorosh, M.; Dobrodumov, A.; Veselkina, O. Creatinyl Amino Acids: New Hybrid Compounds with Neuroprotective Activity J. Pept. Sci. 2011, 17, 620-626
12. Cordon-Cardo, C.; O'Brien, J. P.; Casals, D.; Rittman-Grauer, L.; Biedler, J. L.; Melamed, M. R.; Bertino, J. R. Multidrug-Resistance Gene (P-Glycoprotein) Is Expressed by Endothelial Cells at Blood-Brain Barrier Sites Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 695-698
13. Pehlivan, S. B. Nanotechnology-Based Drug Delivery Systems for Targeting, Imaging and Diagnosis of Neurodegenerative Diseases Pharm. Res. 2013, 30, 2499-2511
14. Kemper, E. M.; van Zandbergen, A. E.; Cleypool, C.; Mos, H. A.; Boogerd, W.; Beijnen, J. H.; van Tellingen, O. Increased Penetration of Paclitaxel into the Brain by Inhibition of P-Glycoprotein Clin. Cancer Res. 2003, 9, 2849-2855
15. Stockwell, J.; Abdi, N.; Lu, X.; Maheshwari, O.; Taghibiglou, C. Novel Central Nervous System Drug Delivery Systems Chem. Biol. Drug Des. 2013, 10.1111/cbdd.12268
16. Song, Q.; Huang, M.; Yao, L.; Wang, X.; Gu, X.; Chen, J.; Chen, J.; Huang, J.; Hu, Q.; Kang, T. et al. Lipoprotein-Based Nanoparticles Rescue the Memory Loss of Mice with Alzheimer's Disease by Accelerating the Clearance of Amyloid-Beta ACS Nano 2014, 10.1021/nn4058215
17. Chapman, C. D.; Frey, W. H., II; Craft, S.; Danielyan, L.; Hallschmid, M.; Schiöth, H. B.; Benedict, C. Intranasal Treatment of Central Nervous System Dysfunction in Humans Pharm. Res. 2013, 30, 2475-2484
18. Born, J.; Lange, T.; Kern, W.; McGregor, G. P.; Bickel, U.; Fehm, H. L. Sniffing Neuropeptides: A Transnasal Approach to the Human Brain Nat. Neurosci. 2002, 5, 514-516
19. Chen, X. Q.; Fawcett, J. R.; Rahman, Y. E.; Ala, T. A.; Frey, W. H., II. Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway J. Alzheimer's Dis. 1998, 1, 35-44
20. Thorne, R. G.; Hanson, L. R.; Ross, T. M.; Tung, D.; Frey, W. H., II. Delivery of Interferon-Beta to the Monkey Nervous System Following Intranasal Administration Neuroscience 2008, 152, 785-797
21. Thorne, R. G.; Pronk, G. J.; Padmanabhan, V.; Frey, W. H., II. Delivery of Insulin-like Growth Factor-I to the Rat Brain and Spinal Cord Along Olfactory and Trigeminal Pathways Following Intranasal Administration Neuroscience 2004, 127, 481-496
22. Yang, J. P.; Liu, H. J.; Cheng, S. M.; Wang, Z. L.; Cheng, X.; Yu, H. X.; Liu, X. F. Direct Transport of VEGF from the Nasal Cavity to Brain Neurosci. Lett. 2009, 449, 108-111
23. De Rosa, R.; Garcia, A. A.; Braschi, C.; Capsoni, S.; Maffei, L.; Berardi, N.; Cattaneo, A. Intranasal Administration of Nerve Growth Factor (NGF) Rescues Recognition Memory Deficits in AD11 Anti-NGF Transgenic Mice Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 3811-3816
24. Illum, L. Is Nose-to-Brain Transport of Drugs in Man a Reality? J. Pharm. Pharmacol. 2004, 56, 3-17
25. Ross, T. M.; Martinez, P. M.; Renner, J. C.; Thorne, R. G.; Hanson, L. R.; Frey, W. H., II. Intranasal Administration of Interferon Beta Bypasses the Blood-Brain Barrier To Target the Central Nervous System and Cervical Lymph Nodes: A Non-invasive Treatment Strategy for Multiple Sclerosis J. Neuroimmunol. 2004, 151, 66-77
26. Thorne, R. G.; Frey, W. H., II. Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations Clin. Pharmacokinet. 2001, 40, 907-946
27. Jin, K.; Xie, L.; Childs, J.; Sun, Y.; Mao, X. O.; Logvinova, A.; Greenberg, D. A. Cerebral Neurogenesis Is Induced by Intranasal Administration of Growth Factors Ann. Neurol. 2003, 53, 405-409
28. Matsuoka, Y.; Gray, A. J.; Hirata-Fukae, C.; Minami, S. S.; Waterhouse, E. G.; Mattson, M. P.; LaFerla, F. M.; Gozes, I.; Aisen, P. S. Intranasal NAP Administration Reduces Accumulation of Amyloid Peptide and Tau Hyperphosphorylation in a Transgenic Mouse Model of Alzheimer's Disease at Early Pathological Stage J. Mol. Neurosci. 2007, 31, 165-170
29. Matsuoka, Y.; Jouroukhin, Y.; Gray, A. J.; Ma, L.; Hirata-Fukae, C.; Li, H. F.; Feng, L.; Lecanu, L.; Walker, B. R.; Planel, E. et al. A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease J. Pharmacol. Exp. Ther. 2008, 325, 146-153
30. Francis, G. J.; Martinez, J. A.; Liu, W. Q.; Xu, K.; Ayer, A.; Fine, J.; Tuor, U. I.; Glazner, G.; Hanson, L. R.; Frey, W. H., II. et al. Intranasal Insulin Prevents Cognitive Decline, Cerebral Atrophy and White Matter Changes in Murine Type I Diabetic Encephalopathy Brain 2008, 131, 3311-3334
31. Reger, M. A.; Watson, G. S.; Green, P. S.; Baker, L. D.; Cholerton, B.; Fishel, M. A.; Plymate, S. R.; Cherrier, M. M.; Schellenberg, G. D.; Frey, W. H., II. et al. Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-Beta in Memory-Impaired Older Adults J. Alzheimer's Dis. 2008, 13, 323-331
32. Benedict, C.; Hallschmid, M.; Schmitz, K.; Schultes, B.; Ratter, F.; Fehm, H. L.; Born, J.; Kern, W. Intranasal Insulin Improves Memory in Humans: Superiority of Insulin Aspart Neuropsychopharmacology 2007, 32, 239-243
33. Hallschmid, M.; Benedict, C.; Schultes, B.; Perras, B.; Fehm, H. L.; Kern, W.; Born, J. Towards the Therapeutic Use of Intranasal Neuropeptide Administration in Metabolic and Cognitive Disorders Regul. Pept. 2008, 149, 79-83
34. Reger, M. A.; Watson, G. S.; Green, P. S.; Wilkinson, C. W.; Baker, L. D.; Cholerton, B.; Fishel, M. A.; Plymate, S. R.; Breitner, J. C.; DeGroodt, W. et al. Intranasal Insulin Improves Cognition and Modulates Beta-Amyloid in Early AD Neurology 2008, 70, 440-448
35. Reger, M. A.; Craft, S. Intranasal Insulin Administration: A Method for Dissociating Central and Peripheral Effects of Insulin Drugs Today 2006, 42, 729-739
36. Furrer, E.; Hulmann, V.; Urech, D. M. Intranasal Delivery of ESBA105, a TNF-Alpha-Inhibitory scFv Antibody Fragment to the Brain J. Neuroimmunol. 2009, 215, 65-72
37. Battaglia, L.; Gallarate, M. Lipid Nanoparticles: State of the Art, New Preparation Methods and Challenges in Drug Delivery Expert Opin. Drug Delivery 2012, 9, 497-508
38. Almeida, A. J.; Souto, E. Solid Lipid Nanoparticles as a Drug Delivery System for Peptides and Proteins Adv. Drug Delivery Rev. 2007, 59, 478-490
39. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
40. Lim, S. B.; Banerjee, A.; Önyüksel, H. Improvement of Drug Safety by the Use of Lipid-Based Nanocarriers J. Controlled Release 2012, 163, 34-45
41. Peer, D.; Park, E. J.; Morishita, Y.; Carman, C. V.; Shimaoka, M. Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-inflammatory Target Science 2008, 319, 627-630
42. des Rieux, A.; Fievez, V.; Garinot, M.; Schneider, Y. J.; Préat, V. Nanoparticles as Potential Oral Delivery Systems of Proteins and Vaccines: A Mechanistic Approach J. Controlled Release 2006, 116, 1-27
43. Pinto Reis, C.; Neufeld, R. J.; Ribeiro, A. J.; Veiga, F. Nanoencapsulation I. Methods for Preparation of Drug-Loaded Polymeric Nanoparticles Nanomedicine 2006, 2, 8-21
44. Al-Jamal, W. T.; Kostarelos, K. Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine Acc. Chem. Res. 2011, 44, 1094-1104
45. Xu, X.; Costa, A.; Burgess, D. J. Protein Encapsulation in Unilamellar Liposomes: High Encapsulation Efficiency and a Novel Technique To Assess Lipid-Protein Interaction Pharm. Res. 2012, 29, 1919-1931
46. Colletier, J. P.; Chaize, B.; Winterhalter, M.; Fournier, D. Protein Encapsulation in Liposomes: Efficiency Depends on Interactions between Protein and Phospholipid Bilayer BMC Biotechnol. 2002, 2, 9
47. Hirai, M.; Kimura, R.; Takeuchi, K.; Hagiwara, Y.; Kawai-Hirai, R.; Ohta, N.; Igarashi, N.; Shimuzu, N. Structure of Liposome Encapsulating Proteins Characterized by X-ray Scattering and Shell-Modeling J. Synchrotron. Radiat. 2013, 20, 869-874
48. Bondí, M. L.; Di Gesú, R.; Craparo, E. F. Lipid Nanoparticles for Drug Targeting to the Brain Methods Enzymol. 2012, 508, 229-251
49. Hernández-Pedro, N. Y.; Rangel-López, E.; Magaa-Maldonado, R.; Pérez de la Cruz, V.; Santamaría del Angel, A.; Pineda, B.; Sotelo, J. Application of Nanoparticles on Diagnosis and Therapy in Gliomas Biomed. Res. Int. 2013, 2013, 351031
50. Soppimath, K. S.; Aminabhavia, T. M.; Kulkarnia, A. R.; Rudzinskib, W. E. Biodegradable Polymeric Nanoparticles as Drug Delivery Devices J. Controlled Release 2001, 70, 1-20
51. Ali, M. E.; Lamprecht, A. Polyethylene Glycol as an Alternative Polymer Solvent for Nanoparticle Preparation Int. J. Pharm. 2013, 456, 135-142
52. Mohamed, F.; van der Walle, C. F. Engineering Biodegradable Polyester Particles with Specific Drug Targeting and Drug Release Properties J. Pharm. Sci. 2008, 97, 71-87
53. Tajmir-Riahi, H. A.; Nafisi, S.; Sanyakamdhorn, S.; Agudelo, D.; Chanphai, P. Applications of Chitosan Nanoparticles in Drug Delivery Methods Mol. Biol. 2014, 1141, 165-184
54. Jain, K. K. Current Status and Future Prospects of Drug Delivery Systems Methods Mol. Biol. 2014, 1141, 1-56
55. Vauthier, C.; Bouchemal, K. Methods for the Preparation and Manufacture of Polymeric Nanoparticles Pharm. Res. 2009, 26, 1025-1058
56. Wissing, S. A.; Kayser, O.; Müller, R. H. Solid Lipid Nanoparticles for Parenteral Drug Delivery Adv. Drug Delivery Rev. 2004, 56, 1257-1272
57. Alyautdin, R.; Khalin, I.; Nafeeza, M. I.; Haron, M. H.; Kuznetsov, D. Nanoscale Drug Delivery Systems and the Blood-Brain Barrier Int. J. Nanomed. 2014, 9, 795-811
58. Kumar, P.; Wu, H.; McBride, J. L.; Jung, K.-E.; Kim, M. H.; Davidson, B. L.; Lee, S. K.; Shankar, P.; Manjunath, N. Transvascular Delivery of Small Interfering RNA to the Central Nervous System Nature 2007, 448, 39-43
59. Mashayekhi, F.; Salehi, Z. Infusion of Anti-nerve Growth Factor into the Cisternum Magnum of Chick Embryo Leads to Decrease Cell Production in the Cerebral Cortical Germinal Epithelium Eur. J. Neurol. 2007, 14, 181-186
60. Capsoni, S.; Giannotta, S.; Cattaneo, A. Nerve Growth Factor and Galantamine Ameliorate Early Signs of Neurodegeneration in Anti-nerve Growth Factor Mice Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 12432-12437
61. Kurakhmaeva, K. B.; Djindjikhashvili, I. A.; Petrov, V. E.; Balabanyan, V. U.; Voronina, T. A.; Trofimov, S. S.; Kreuter, J.; Gelperina, S.; Begley, D.; Alyautdin, R. N. Brain Targeting of Nerve Growth Factor Using Poly(butyl cyanoacrylate) Nanoparticles J. Drug Targeting 2009, 17, 564-574
62. Kreuter, J.; Hekmatara, T.; Dreis, S.; Vogel, T.; Gelperina, S.; Langer, K. Covalent Attachment of Apolipoprotein A-I and Apolipoprotein B-100 to Albumin Nanoparticles Enables Drug Transport into the Brain J. Controlled Release 2007, 118, 54-58
63. Kreuter, J.; Shamenkov, D.; Petrov, V.; Ramge, P.; Cychutek, K.; Koch-Brandt, C.; Alyautdin, R. Apolipoprotein-Mediated Transport of Nanoparticle-Bound Drugs Across the Blood-Brain Barrier J. Drug Targeting 2002, 10, 317-325
64. Petri, B.; Bootz, A.; Khalansky, A.; Hekmatara, T.; Müller, R.; Uhl, R.; Kreuter, J.; Gelperina, S. Chemotherapy of Brain Tumour Using Doxorubicin Bound to Surfactant-Coated Poly(butyl cyanoacrylate) Nanoparticles: Revisiting the Role of Surfactants J. Controlled Release 2007, 117, 51-58
65. Kurakhmaeva, K. B.; Voronina, T. A.; Kapica, I. G.; Kreuter, J.; Nerobkova, L. N.; Seredenin, S. B.; Balabanian, V. Y.; Alyautdin, R. N. Antiparkinsonian Effect of Nerve Growth Factor Adsorbed on Polybutylcyanoacrylate Nanoparticles Coated with Polysorbate-80 Bull. Exp. Biol. Med. 2008, 145, 259-262
66. Xie, Y.; Ye, L.; Zhang, X.; Cui, W.; Lou, J.; Nagai, T.; Hou, X. Transport of Nerve Growth Factor Encapsulated into Liposomes Across the Blood-Brain Barrier: In Vitro and In Vivo Studies J. Controlled Release 2005, 105, 106-119
67. Migliore, M. M.; Vyas, T. K.; Campbell, R. B.; Amiji, M. M.; Waszczak, B. L. Brain Delivery of Proteins by the Intranasal Route of Administration: A Comparison of Cationic Liposomes versus Aqueous Solution Formulations J. Pharm. Sci. 2010, 99, 1745-1761